SK151395A3 - Heterocyclic amide compounds, preparation method thereof, pharmaceutical compositions and their use - Google Patents
Heterocyclic amide compounds, preparation method thereof, pharmaceutical compositions and their use Download PDFInfo
- Publication number
- SK151395A3 SK151395A3 SK1513-95A SK151395A SK151395A3 SK 151395 A3 SK151395 A3 SK 151395A3 SK 151395 A SK151395 A SK 151395A SK 151395 A3 SK151395 A3 SK 151395A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- heterocyclic amides
- mmol
- alkyl
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0225294A AT402926B (de) | 1994-12-05 | 1994-12-05 | Heterocyclische amide, verfahren zu ihrer herstellung und verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
SK151395A3 true SK151395A3 (en) | 1996-06-05 |
Family
ID=3530873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1513-95A SK151395A3 (en) | 1994-12-05 | 1995-11-30 | Heterocyclic amide compounds, preparation method thereof, pharmaceutical compositions and their use |
Country Status (15)
Country | Link |
---|---|
US (1) | US5627198A (no) |
EP (1) | EP0716087A1 (no) |
JP (1) | JPH08225553A (no) |
CN (1) | CN1132204A (no) |
AT (1) | AT402926B (no) |
AU (1) | AU4021595A (no) |
CA (1) | CA2164375A1 (no) |
CZ (1) | CZ321695A3 (no) |
FI (1) | FI955818A (no) |
HU (1) | HUT75064A (no) |
IL (1) | IL116245A0 (no) |
NO (1) | NO954913L (no) |
NZ (1) | NZ280589A (no) |
SK (1) | SK151395A3 (no) |
ZA (1) | ZA9510305B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6407124B1 (en) | 1998-06-18 | 2002-06-18 | Bristol-Myers Squibb Company | Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
TWI271402B (en) * | 2002-10-15 | 2007-01-21 | Tanabe Seiyaku Co | Large conductance calcium-activated K channel opener |
DK2528621T3 (da) | 2010-01-27 | 2017-01-02 | Glaxosmithkline Biologicals Sa | Modificerede tuberkuloseantigener |
CN110117263B (zh) * | 2019-06-11 | 2020-12-25 | 湖南中医药大学 | 2-氨基-5-酰基噻唑衍生物及其合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3051M (fr) * | 1963-11-15 | 1965-01-04 | Bruneau & Cie Lab | Médicament a base de dérivé de thiadiazol. |
TW205041B (no) * | 1989-08-07 | 1993-05-01 | Fujisawa Pharmaceutical Co | |
GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
GB9305295D0 (en) * | 1993-03-15 | 1993-05-05 | Zeneca Ltd | Therapeutic compounds |
-
1994
- 1994-12-05 AT AT0225294A patent/AT402926B/de not_active IP Right Cessation
-
1995
- 1995-11-24 EP EP95118497A patent/EP0716087A1/de not_active Withdrawn
- 1995-11-30 SK SK1513-95A patent/SK151395A3/sk unknown
- 1995-12-04 US US08/567,057 patent/US5627198A/en not_active Expired - Fee Related
- 1995-12-04 JP JP7315358A patent/JPH08225553A/ja not_active Withdrawn
- 1995-12-04 AU AU40215/95A patent/AU4021595A/en not_active Abandoned
- 1995-12-04 CN CN95120215A patent/CN1132204A/zh active Pending
- 1995-12-04 FI FI955818A patent/FI955818A/fi not_active Application Discontinuation
- 1995-12-04 IL IL11624595A patent/IL116245A0/xx unknown
- 1995-12-04 HU HU9503466A patent/HUT75064A/hu unknown
- 1995-12-04 NZ NZ280589A patent/NZ280589A/en unknown
- 1995-12-04 NO NO954913A patent/NO954913L/no unknown
- 1995-12-04 CA CA002164375A patent/CA2164375A1/en not_active Abandoned
- 1995-12-05 CZ CZ953216A patent/CZ321695A3/cs unknown
- 1995-12-05 ZA ZA9510305A patent/ZA9510305B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HU9503466D0 (en) | 1996-01-29 |
US5627198A (en) | 1997-05-06 |
ZA9510305B (en) | 1996-06-11 |
NO954913D0 (no) | 1995-12-04 |
IL116245A0 (en) | 1996-03-31 |
ATA225294A (de) | 1997-02-15 |
NZ280589A (en) | 1996-08-27 |
CN1132204A (zh) | 1996-10-02 |
EP0716087A1 (de) | 1996-06-12 |
JPH08225553A (ja) | 1996-09-03 |
AU4021595A (en) | 1996-06-13 |
FI955818A0 (fi) | 1995-12-04 |
NO954913L (no) | 1996-06-06 |
FI955818A (fi) | 1996-06-06 |
AT402926B (de) | 1997-09-25 |
HUT75064A (en) | 1997-03-28 |
CA2164375A1 (en) | 1996-06-06 |
CZ321695A3 (en) | 1996-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI112940B (fi) | Menetelmä terapeuttisesti käyttökelpoisen amidin valmistamiseksi | |
AU2009209885B2 (en) | Thiazole derivative and use thereof as VAP-1 inhibitor | |
JP5225076B2 (ja) | チアゾール環を含むカルボン酸誘導体の医薬用途 | |
AU2002334817B2 (en) | Thiopene- and Thiazolesulfonamides as Antineoplastic Agents | |
MX2007016319A (es) | Derivados de n-(piridin-2-il)-sulfonamida. | |
KR20080002832A (ko) | 보체 매개성 질병 및 이상을 치료하기 위한 신규한 티오펜설폭시민 | |
RU2299202C2 (ru) | N-фениларилсульфонамид, фармацевтическая композиция, содержащая указанное соединение в качестве активного ингредиента, соединение, являющееся промежуточным в синтезе указанного соединения, и способ его получения | |
AU2002334817A1 (en) | Thiopene- and Thiazolesulfonamides as Antineoplastic Agents | |
NO162237B (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
WO1999062892A1 (en) | Aminoazole compounds | |
CA2080949A1 (en) | Therapeutic agents | |
JP3723589B2 (ja) | イソオキサゾール誘導体 | |
US10221147B2 (en) | Heterocyclic compounds with working memory enhancing activity | |
SK151395A3 (en) | Heterocyclic amide compounds, preparation method thereof, pharmaceutical compositions and their use | |
CN108383828A (zh) | 作为趋化因子受体调节剂的新的1,2-双-磺酰胺衍生物 | |
EP0180500A1 (fr) | Dérivés de thiéno et furo - [2,3-c]pyrroles, procédés de préparation et médicaments les contenant | |
CZ281710B6 (cs) | Nitroxyalkylamidové deriváty, způsob výroby a farmaceutické prostředky s jejich obsahem | |
EP2985279B1 (en) | Heterocyclic compounds with working memory enhancing activity | |
CA2063865A1 (en) | 2-(substituted imino)-thiazolidines and process for the preparation thereof | |
DE19506652A1 (de) | Heterocyclische Amide, Verfahren zu ihrer Herstellung und ihre Verwendung | |
JPH05503096A (ja) | 新規のチアゾール誘導体 | |
PL171991B1 (pl) | Sposób wytwarzania nowych amidów | |
WO2001094326A1 (fr) | Nouveaux derives de thiazolidinedione et utilisation de ceux-ci comme medicament | |
JPH0812659A (ja) | チアゾール誘導体及びこれを含有する医薬製剤 |